Cochlear Implantation Outcomes in Patients With Retrocochlear Pathology: A Systematic Review and Pooled Analysis.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
pubmed:
2
9
2022
medline:
20
9
2022
entrez:
1
9
2022
Statut:
ppublish
Résumé
To review the current literature regarding cochlear implantation in patients with retrocochlear pathologies and extract speech perception scores between 6 months and 1 year after surgery. PubMed/MEDLINE, Embase and Cochrane CENTRAL via Ovid, CINAHL Complete via Ebsco, and Web of Science. The review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Search strategies included keywords and subject headings to maximize retrieval and reflect cochlear implants and retrocochlear pathologies. Patients with previously resected vestibular schwannoma (VS) were excluded. There were 2,524 abstracts screened against inclusion criteria, and 53 studies were included, with individual data available for 171 adult patients. Pathologies included were either observed or irradiated VS (previously operated tumors were excluded) (n = 99, 57.9%), superficial siderosis (n = 39, 22.8%), neurosarcoidosis (n = 11, 6.4%), and previous central nervous system or skull base radiation (n = 22, 12.9%). Mean (standard deviation) postoperative consonant-nucleus-consonant (CNC) word scores were 45.4% (24.2) for observed VS, 44.4% (20.8) for irradiated VS, 43.6% (21.0) for superficial siderosis, 89.5% (3.0) for neurosarcoidosis, and 30.0% (30.2) in patients with previous central nervous system or skull base irradiation. Irradiated compared with observed VS had similar postoperative CNC word scores (effect size, 0.06; p = 0.71). Age, sex, maximal tumor dimension, and neurofibromatosis type 2 status did not significantly impact cochlear implant performance in patients with VS. Eighty-two percent of patients with reported device usage were daily users, and overall, 82% of cases benefitted from cochlear implantation. Cochlear implantation in patients with concomitant retrocochlear pathology generally results in improved speech discrimination scores sustained over time.
Identifiants
pubmed: 36047686
doi: 10.1097/MAO.0000000000003648
pii: 00129492-202210000-00002
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
980-986Informations de copyright
Copyright © 2022, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
J.T.R. is on the advisory board for Cochlear Pty Limited. S.O.M. is an advisor for Advanced Bionics. The remaining authors disclose no conflicts of interest.
Références
Hoffman RA, Kohan D, Cohen NL. Cochlear implants in the management of bilateral acoustic neuromas. Am J Otolaryngol 1992;13:525–8.
Patel EJ, Deep NL, Friedmann DR, et al. Cochlear implantation in sporadic vestibular schwannoma and other etrocochlear pathology: a case series. Otol Neurotol 2021;42:e425–32.
West N, Sass H, Cayé-Thomasen P. Sporadic and NF2-associated vestibular schwannoma surgery and simultaneous cochlear implantation: a comparative systematic review. Eur Arch Otorhinolaryngol 2020;277:333–42.
Wick CC, Butler MJ, Yeager LH, et al. Cochlear implant outcomes following vestibular schwannoma resection: systematic review. Otol Neurotol 2020;41:1190–7.
Deep NL, Patel EJ, Shapiro WH, et al. Cochlear implant outcomes in neurofibromatosis type 2: implications for management. Otol Neurotol 2021;42:540–8.
North HJ, Mawman D, O'Driscoll M, et al. Outcomes of cochlear implantation in patients with neurofibromatosis type 2. Cochlear Implants Int 2016;17:172–7.
Smith ME, Edmiston R, Trudel M, et al. Cochlear implantation in neurofibromatosis type 2: experience from the UK neurofibromatosis type 2 service. Otol Neurotol 2022;43:538–46.
Eitutis ST, Jansen T, Borsetto D, et al. Cochlear implantation in NF2 patients without intracochlear schwannoma removal. Otol Neurotol 2021;42:1014–21.
Mukherjee P, Ramsden JD, Donnelly N, et al. Cochlear implants to treat deafness caused by vestibular schwannomas. Otol Neurotol 2013;34:1291–8.
Harris F, Tysome JR, Donnelly N, et al. Cochlear implants in the management of hearing loss in neurofibromatosis type 2. Cochlear Implants Int 2017;18:171–9.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
Howick J. The Oxford 2011 levels of evidence. http://wwwcebmnet/indexaspx?o=5653 . 2011.
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.
Hardin JW, Hilbe JM. Generalized estimating equations . Chapman and Hall/CRC; 2002.
Alshehabi M, Walshe P, Viani L. Cochlear implantation in the presence of superficial siderosis. Clin Otolaryngol 2019;44:1166–9.
Amoodi HA, Makki FM, Cavanagh J, Maessen H, Bance M. Cochlear implant rehabilitation for patients with vestibular schwannoma: report of two cases. Cochlear Implants Int 2012;13:124–7.
Artukarslan E, Matin F, Donnerstag F, et al. Cochlea implantation in patients with superficial hemosiderosis. Eur Arch Otorhinolaryngol 2021.
Berrettini S, De Vito A, Bruschini L, Fortunato S, Forli F. Cochlear implantation in patients affected by superficial hemosiderosis of the central nervous system. Eur Arch Otorhinolaryngol 2012;269:25–31.
Bird PA, Monteath P, Healy L. Successful cochlear implantation in a patient with superficial siderosis of the central nervous system. Otol Neurotol 2010;31:177.
Bittencourt AG, Goffi-Gomez MV, Pinna MH, et al. Programming peculiarities in two cochlear implant users with superficial siderosis of the central nervous system. Eur Arch Otorhinolaryngol 2012;269:1555–63.
Carlson ML, Breen JT, Driscoll CL, et al. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol 2012;33:853–62.
Carlson ML, Neff BA, Sladen DP, Link MJ, Driscoll CL. Cochlear implantation in patients with intracochlear and intralabyrinthine schwannomas. Otol Neurotol 2016;37:647–53.
Clarke L. Neurofibromatosis 2—a family journey. Can J Neurosci Nurs 2009;31:7–14.
Costello MS, Golub JS, Barrord JV, et al. Cochlear implantation after radiation therapy for acoustic neuroma. J Radiosurg SBRT 2016;4:69–74.
Ebode D, Cohen-Aubart F, Trunet S, et al. Cochlear implant outcomes in patients with neurosarcoidosis. Audiol Neurootol 2021;26:454–60.
Formanek M, Czerny C, Gstoettner W, Kornfehl J. Cochlear implantation as a successful rehabilitation for radiation-induced deafness. Eur Arch Otorhinolaryngol 1998;255:175–8.
Fujimoto C, Ito K, Takano S, Karino S, Iwasaki S. Successful cochlear implantation in a patient with bilateral progressive sensorineural hearing loss after traumatic subarachnoid hemorrhage and brain contusion. Ann Otol Rhinol Laryngol 2007;116:897–901.
Greene JJ, Naumann IC, Poulik JM, et al. The protean neuropsychiatric and vestibuloauditory manifestations of neurosarcoidosis. Audiol Neurootol 2017;22:205–17.
Grover N, Whiteside OJ, Ramsden JD. Cochlear implantation in superficial siderosis: a viable option? Cochlear Implants Int 2011;12:241–3
Halyur DA, Rayanagoudar PH, Kumar A, Dutt SN. Neurofibromatosis 2: primary modality of hearing rehabilitation with cochlear implant. Indian J Otol Head Neck Surg 2021;73:395–400.
Hathaway B, Hirsch B, Branstetter B. Successful cochlear implantation in a patient with superficial siderosis. Am J Otolaryngol 2006;27:255–8.
Häußler SM, Szczepek AJ, Gräbel S, et al. Hearing rehabilitation with cochlear implants after CyberKnife radiosurgery of vestibular schwannoma: a report based on four clinical cases. Brain Sci 2021;11:1646.
Helbig S, Rader T, Bahmer A, Baumann U. A case of bilateral cochlear implantation in single-sided untreated acoustic neurinoma. Acta Otolaryngol 2009;129:694–6.
Huang Y, Wang X, Huang H, et al. Long-term outcomes of cochlear implantation in irradiated ears of nasopharyngeal carcinoma patients. Laryngoscope 2021;131:649–55.
Huo Z, Zhang Z, Huang Q, et al. Hearing restoration for adults with vestibular schwannoma in the only hearing ear: ipsilateral or contralateral cochlear implantation? ORL J Otorhinolaryngol Relat Spec 2016;78:281–8.
Irving RM, Graham JM. Cochlear implantation in superficial siderosis. J Laryngol Otol 1996;110:1151–3.
Jia H, Nguyen Y, De Seta D, et al. Management of sporadic vestibular schwannoma with contralateral nonserviceable hearing. Laryngoscope 2020;130:E407–15.
Longino ES, Manzoor NF, Cass ND, et al. Cochlear implantation outcomes in observed vestibular schwannoma: a preliminary report. Otolaryngol Head Neck Surg 2021;167:149–54.
Low WK, Gopal K, Goh LK, Fong KW. Cochlear implantation in postirradiated ears: outcomes and challenges. Laryngoscope 2006;116:1258–62.
Lustig LR, Yeagle J, Driscoll CL, et al. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. Otol Neurotol 2006;27:512–8.
Medina Mdel M, Piccirillo E, D'Orazio F, et al. Cochlear implantation in irradiated tympanojugular paraganglioma. Int J Audiol 2015;54:987–90.
Modest MC, Carlson ML, Wanna GB, Driscoll CL. Cochlear implantation in patients with superficial Siderosis: seven cases and systematic review of the literature. Otol Neurotol 2015;36:1191–6.
Nogueira C, Meehan T. Successful outcome of cochlear implantation in a patient with superficial siderosis. B-ENT 2012;8:57–9.
Omichi R, Kariya S, Maeda Y, Nishizaki K. Cochlear implantation is a therapeutic option for superficial siderosis patients with sensorineural hearing loss. J Laryngol Otol 2016;130:408–11.
Pai I, Dhar V, Kelleher C, et al. Cochlear implantation in patients with vestibular schwannoma: a single United Kingdom center experience. Laryngoscope 2013;123:2019–23.
Patel NS, Carlson ML, Link MJ, et al. Cochlear implantation after radiosurgery for vestibular schwannoma. J Neurosurg 2021;135:126–35.
Pimentel PS, Ramos DS, Muniz L, Leal Mde C, Caldas Neto Sda S. Cochlear implant in a patient with neurofibromatosis type 2 undergoing radiotherapy. Braz J Otorhinolaryngol 2016;82:242–3.
Pisa J, Sulkers J, Butler JB, West M, Hochman JB. Stereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II. J Radiosurg SBRT 2017;5:63–71.
Roehm PC, Mallen-St Clair J, Jethanamest D, et al. Auditory rehabilitation of patients with neurofibromatosis type 2 by using cochlear implants. J Neurosurg 2011;115:827–34.
Ryan M, Piplica D, Zhang M. Case report: cochlear implantation in a patient with superficial siderosis. Otol Neurotol 2014;35:1742–5.
Sugimoto H, Ito M, Hatano M, Yoshizaki T. Cochlear implantation in a patient with superficial siderosis. Auris Nasus Larynx 2012;39:623–6.
Svrakic M, Golfinos JG, Zagzag D, Roland JT Jr. Cochlear implantation of a patient with definitive neurosarcoidosis. OTO Open 2017;1:2473974X17742633.
Sydlowski SA, Cevette MJ, Shallop J, Barrs DM. Cochlear implant patients with superficial siderosis. J Am Acad Audiol 2009;20:348–52.
Tan H, Jia H, Li Y, et al. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2. Eur Arch Otorhinolaryngol 2018;275:2667–74.
Tian L, West N, Cayé-Thomasen P. Cochlear implantation after radiotherapy of vestibular schwannomas. J Int Adv Otol 2021;17:452–60.
Tolisano AM, Baumgart B, Whitson J, Kutz JW Jr. Cochlear implantation in patients with neurofibromatosis type 2. Otol Neurotol 2019;40:e381–5.
Trotter MI, Briggs RJ. Cochlear implantation in neurofibromatosis type 2 after radiation therapy. Otol Neurotol 2010;31:216–9.
Urban MJ, Moore DM, Kwarta K, et al. Ipsilateral cochlear implantation in the presence of observed and irradiated vestibular schwannomas. Ann Otol Rhinol Laryngol 2020;129:1229–38.
Wood VH, Bird PA, Giles EC, Baber WJ. Unsuccessful cochlear implantation in two patients with superficial siderosis of the central nervous system. Otol Neurotol 2008;29:622–5.
Yazama H, Hasegawa K, Kunimoto Y, Watanabe T, Fujiwara K. A case of cochlear implantation in a patient with superficial siderosis. Yonago Acta Med 2021;64:222–8.
Yue V, Leung EK, Wong TK, Tong MC, Van Hasselt CA. Cochlear implantation for post-irradiation deafness. Cochlear Implants Int 2004;5(Suppl 1):165–8.
Bartindale MR, Tadokoro KS, Kircher ML. Cochlear implantation in sporadic vestibular schwannoma: a systematic literature review. J Neurol Surg B Skull Base 2019;80:632–9.
Tadokoro K, Bartindale MR, El-Kouri N, et al. Cochlear implantation in vestibular schwannoma: a systematic literature review. J Neurol Surg B Skull Base 2021;82:643–51.
Borsetto D, Hammond-Kenny A, Tysome JR, et al. Hearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: a systematic review. Cochlear Implants Int 2020;21:9–17.
Wackym PA, Runge-Samuelson CL, Nash JJ, et al. Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss. Otol Neurotol 2010;31:1480–7.
Neff BA, Wiet RM, Lasak JM, et al. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 2007;117:1069–72.
Vincenti V, Pasanisi E, Guida M, Di Trapani G, Sanna M. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurootol 2008;13:273–80.
Babin RW, Liu C, Aschenbrener C. Histopathology of neurosensory deafness in sarcoidosis. Ann Otol Rhinol Laryngol 1984;93(4 Pt 1):389–93.
Colvin IB. Audiovestibular manifestations of sarcoidosis: a review of the literature. Laryngoscope 2006;116:75–82.
Dhanjal H, Rainsbury J, Irving RM. Bilateral sensorineural hearing loss and labyrinthitis ossificans secondary to neurosarcoidosis. Cochlear Implants Int 2014;15:337–40.
Iwanowski L, Olszewski J. The effects of subarachnoid injections of iron-containing substances on the central nervous system. J Neuropathol Exp Neurol 1960;19:433–48.
Coplan J, Post EM, Richman RA, Grimes CT. Hearing loss after therapy with radiation. Am J Dis Child 1981;135:1066–7.
Low WK, Burgess R, Fong KW, Wang DY. Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope 2005;115:1823–6.
Adunka OF, Buchman CA. Cochlear implantation in the irradiated temporal bone. J Laryngol Otol 2007;121:83–6.